ESG
World AIDS Day
World AIDS Day is held on 1 December each year. It raises awareness across the world and in the community about HIV and AIDS.
In the 2019–20 Budget, the Morrison Government invested $45.4 million to implement Australia’s five National Blood-Borne Viruses (BBV) and Sexually Transmissible Infections (STI) Strategies.
These strategies will make a deep and profound difference in reducing the health impacts and stigma of BBV and STI, including HIV.
The Government will provide additional, ongoing support for people with HIV and other BBV and STI’s by extending funding to six national peak organisations, providing almost $3 million for 2020-21.
In addition, from 1 December 2019, Australians living with HIV will save more than $8,500 a year with the listing of a new combination medicine on the Pharmaceutical Benefits Scheme (PBS).
It is estimated that 850 Australians with HIV will benefit from the listing of Dovato (dolutegravir with lamivudine) on the PBS, which will provide more choice for them in how they can manage their HIV.
You may also like Scientists in every boardroom by Dr Ruby Campbell.
Effective once daily treatments such as Dovato and other new medicines can control the virus so that people living with HIV can enjoy long, healthy and productive lives.
Australia continues to be a world leader in the response to HIV. The number of new HIV diagnoses today is at its lowest in nearly 20 years.
The Eighth National HIV Strategy 2018-22, guides our partnership approach over the next four years to virtual elimination of HIV transmission by 2022.
The aim is to be one of the first countries in the world to eliminate new HIV transmissions.
Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.
Medical and Science
NACCHO-Pfizer partnership ignites global journey for First Nations pharmacy leaders
Medical & Science: NACCHO has announced the recipients of the 2024 Aboriginal and Torres Strait Islander Pharmacy Leadership Grant: Jes […]
MoreNews & Trends - Pharmaceuticals
Expanded access to Shingrix is a start: ‘We need reform for all current and future vaccines’
Pharma News: Access to GSK’s Shingrix vaccine, following the 2023-24 federal budget decision, has been limited to “immunocompromised patients aged […]
MoreNews & Trends - Pharmaceuticals
NSW government fails to back mental health inquiry findings with essential funding
NSW Government has support for 24 of 39 recommendations from the Portfolio Committee’s Inquiry Report on ‘Equity, accessibility and appropriate […]
More